Your browser doesn't support javascript.
loading
BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells.
Yu, Yaya; Xiao, Zhenzhen; Lei, Chenjing; Ma, Changju; Ding, Lina; Tang, Qing; He, Yihan; Chen, Yadong; Chang, Xuesong; Zhu, Yanjuan; Zhang, Haibo.
Affiliation
  • Yu Y; The Second Clinical Medical School of Guangzhou University of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Xiao Z; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Lei C; The Second Clinical Medical School of Guangzhou University of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Ma C; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Ding L; The Second Clinical Medical School of Guangzhou University of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Tang Q; The Second Clinical Medical School of Guangzhou University of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • He Y; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Chen Y; The Second Clinical Medical School of Guangzhou University of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Chang X; The Second Clinical Medical School of Guangzhou University of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Zhu Y; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
  • Zhang H; The Second Clinical Medical School of Guangzhou University of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
BMC Cancer ; 23(1): 732, 2023 Aug 08.
Article in En | MEDLINE | ID: mdl-37553597

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: China